Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan

被引：2
|
作者：
Aqeel, Faten [1 ]
Zonozi, Reza [2 ,3 ]
Jeyabalan, Anushya [2 ,3 ]
Sauvage, Gabriel [4 ]
Niles, John L. [4 ]
Geetha, Duvuru [1 ]
机构：
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA
[2] Massachusetts Gen Hosp, Vasculitis & Glomerulonephritis Ctr, Div Nephrol, Boston, MA 02114 USA
[3] Harvard Med Sch, Dept Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
来源：
RMD OPEN | 2023年 / 9卷 / 03期
关键词：
COVID-19; Systemic vasculitis; Vaccination;
D O I：
10.1136/rmdopen-2023-003435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Avacopan for Patients with ANCA-associated Vasculitis
    Rauen, Thomas
    Kraemer, Stefan
    Floege, Juergen
    NEPHROLOGIE, 2022, 17 (02): : 117 - 118
  • [2] Outcomes of COVID-19 in Patients with ANCA-Associated Vasculitis (AAV)
    El Sharu, Husam
    Mubaydeen, Teeba
    Noboa, Maria Romero
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1493 - 1494
  • [3] Avacopan for the Treatment of ANCA-Associated Vasculitis
    Matsuo, Yusuke
    Miyabe, Yoshishige
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21):
  • [4] Avacopan for the treatment of ANCA-associated vasculitis
    Osman, Mohammed
    Cohen Tervaert, Jan Willem
    Pagnoux, Christian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 717 - 726
  • [5] Fatigue in patients with ANCA-associated vasculitis: is avacopan the answer?
    Tervaert, Jan Willem Cohen
    LANCET RHEUMATOLOGY, 2023, 5 (08): : E429 - E430
  • [6] ANCA-associated vasculitis after COVID-19
    Tugba Izci Duran
    Ercan Turkmen
    Melda Dilek
    Hayriye Sayarlioglu
    Nurol Arik
    Rheumatology International, 2021, 41 : 1523 - 1529
  • [7] Avacopan for the Treatment of ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Schall, Thomas J.
    Bekker, Pirow
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 599 - 609
  • [8] Avacopan in the treatment of ANCA-associated vasculitis
    Tesar, Vladimir
    Hruskova, Zdenka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (05) : 491 - 496
  • [9] ANCA-associated vasculitis after COVID-19
    Duran, Tugba Izci
    Turkmen, Ercan
    Dilek, Melda
    Sayarlioglu, Hayriye
    Arik, Nurol
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (08) : 1523 - 1529
  • [10] Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Springer, Jason
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (02) : 223 - 232
12345